Life Sciences


phase 3 approval
May 19 • Risk Management

FDA Phase 3 Approval: What Insurance Do I Need?

Update: We’ve released a new whitepaper examining the Biotech industry. We dive into the insurance landscape, funding, legal climate, and how to approach risk management for companies in this sector. You can download the report here! Most life sciences professionals understand the FDA drug-approval process. Or, at least, you are aware of how painstaking it is to


life science VC
May 12 • Directors & Officers

VC Funding for Life Sciences Companies

VC funding for life sciences companies has evolved significantly in the past two decades. Here’s what you need to know about financing in the space.


biotech_lifescience_startups
March 12 • Thought Leadership

Top 10 Biotech & Life Science Startups

Plenty of biotech and life science startups launched in late-2018. Here’s a list of the top ten making waves in this space.


ESOPs
September 17 • Directors & OfficersFiduciary Liability

ESOPs: Do They Impact D&O Insurance?

Plenty of risks are associated with ESOPs. But, how do they impact your current D&O, E&O, or general liability insurance policy. Here’s the scoop.